| Symbol | CAMP |
|---|---|
| Name | CAMP4 THERAPEUTICS CORP |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | ONE KENDALL SQUARE, CAMBRIDGE, MA 02139 |
| Telephone | 617-651-8867 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001736730 |
| Description | None |
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
Read moreCAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Read moreGold Kelly 🟢 acquired 10.0K shares of Camp4 Therapeutics Corp (CAMP) at $3.96 Transaction Date: Aug 31, 2026 | Filing ID: 060234
Read moreSchwab Andrew J. 🔴 sold 400.0K shares of Camp4 Therapeutics Corp (CAMP) at $4.04 ($1.6M) Transaction Date: Aug 27, 2026 | Filing ID: 000011
Read moreNew Form SCHEDULE 13D/A - Camp4 Therapeutics Corp <b>Filed:</b> 2026-08-31 <b>AccNo:</b> 0001753037-26-000007 <b>Size:</b> 20 KB
Read moreSchwab Andrew J. 🔴 sold 191.9K shares of Camp4 Therapeutics Corp (CAMP) at $4.76 Transaction Date: Aug 19, 2026 | Filing ID: 000007
Read moreTardiff Daniel 🔴 sold 1.7K shares of Camp4 Therapeutics Corp (CAMP) at $4.76 Transaction Date: Aug 19, 2026 | Filing ID: 058107
Read moreNew Form SCHEDULE 13D/A - Camp4 Therapeutics Corp <b>Filed:</b> 2026-08-19 <b>AccNo:</b> 0001193125-26-357272 <b>Size:</b> 22 KB
Read more📋 Daniel Tardiff (affiliate) plans to sell 2K shares of CAMP4 Therapeutics Corporation (at $4.76 each, total $8K) Filed: Aug 19, 2026 | ID: 000263
Read more